Ekman-Ordeberg G, Uldbjerg N, Ulmsten U
Obstet Gynecol. 1985 Sep;66(3):307-10.
To induce cervical priming and labor, 20 nulliparous term pregnant women with premature rupture of the membranes and unfavorable cervical states were randomly given either oxytocin intravenously or 4 mg prostaglandin E2 in gel intravaginally. One of ten women receiving oxytocin had a favorable cervical state within five hours and vaginal delivery within 24 hours after the start of the infusion compared with six of ten women after prostaglandin E2 gel application. This difference is statistically significant (P less than .01). The number of instrumental deliveries was nine (four cesarean sections and five vacuum extractions) in the oxytocin-treated patients compared with only two vacuum extractions in women who received prostaglandin E2 gel. This difference is also statistically significant (P less than .01, Fischer exact test). In a subsequent open study, 4 mg prostaglandin E2 gel was applied vaginally to 17 term pregnant women of mixed parity with premature rupture of the membranes and unfavorable cervixes. In 12 women a favorable cervical state was achieved within five hours after gel application, and all these women were delivered within 24 hours. None of the women required cesarean section but two required delivery by vacuum extraction. There were no perinatal losses, but two infants in the oxytocin-treated group had Apgar scores less than 7 at five minutes. At pediatric follow-up after two and six months, all infants were normal. In both obstetric and perinatal outcome prostaglandin E2 gel thus seems to be superior to oxytocin for labor induction in term pregnant patients with premature rupture of the membranes and unfavorable cervixes.
为诱导宫颈成熟和发动分娩,将20名胎膜早破且宫颈条件不佳的初产妇随机分为两组,一组静脉滴注缩宫素,另一组阴道内给予4mg前列腺素E2凝胶。与接受前列腺素E2凝胶的10名产妇中的6名相比,接受缩宫素的10名产妇中有1名在5小时内宫颈条件改善,并在开始输注后24小时内阴道分娩。这种差异具有统计学意义(P<0.01)。缩宫素治疗组有9例器械助产(4例剖宫产和5例真空吸引),而接受前列腺素E2凝胶的产妇中只有2例真空吸引。这种差异也具有统计学意义(P<0.01,Fisher精确检验)。在随后的一项开放性研究中,对17名胎膜早破且宫颈条件不佳的经产妇和初产妇足月孕妇阴道内应用4mg前列腺素E2凝胶。12名产妇在凝胶应用后5小时内宫颈条件改善,所有这些产妇均在24小时内分娩。无一例产妇需要剖宫产,但有2例需要真空吸引助产。无围产期死亡,但缩宫素治疗组有2例婴儿5分钟时Apgar评分低于7分。在出生后2个月和6个月的儿科随访中,所有婴儿均正常。因此,对于胎膜早破且宫颈条件不佳的足月孕妇引产,前列腺素E2凝胶在产科和围产期结局方面似乎优于缩宫素。